Talk:Xylometazoline: Difference between revisions

Content deleted Content added

Inline

Latest revision as of 20:45, 28 December 2024

This is the talk page for discussing improvements to the Xylometazoline article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Xylometazoline.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

@@ Line 10: / Line 10: @@
 |box-advert=no
 }}
-==Untitled==
-"'''1% w/v xylometazoline'''" dose?! My spray (ratiopharm NasenSpray) is a 0.1 % solution - maybe the figure is wrong in the article? Also, i don't understand the concept of drug resistance to xylmetazoline - as it does the same as adrenaline, a person with high adrenaline production should have chronic nose congestion as well.
-actually, if you took xylometazoline too long, and you get chronic congestion, will the chronic congestion fade away after some time?
-Thanks,
---[[User:Abdull|Abdull]] 17:48, 10 Jun 2005 (UTC)
-The question should be why is there congestion in the first place? and why would any sane person use a drug to remove the sympton for a short while only to make it worst in the future?
-I read somewhere that a lack of water in the body is one thing that affects allergies so drinking more water should help.  <small>—Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/195.157.148.189|195.157.148.189]] ([[User talk:195.157.148.189|talk]]) 12:21, 27 November 2007 (UTC)</small><!-- Template:UnsignedIP --> <!--Autosigned by SineBot-->
-I'd like to bring up the point about resistance to Xylometazoline too. I have a relative thathas been using Otrivine day-to-day for the past couple of years, without decreased effectiveness. I do not understand why the number of receptors would decrease after prologned usage. "'' Prolonged use of xylometazoline '''may''' result in tolerance or a decreased effect of the drug. Both a decrease in the decongestant duration and effect occurs possibly due to receptor down-regulation''" [http://harrisonspractice.com/practice/ub?cmd=ref&style.cp=421620&style.cpa=0 source]. The article implies that in all cases the vessel becomes resistant (because of the omission of 'can'). This really needs to be cleared up and sourced. [[User:Balazsh|Balazsh]] ([[User talk:Balazsh|talk]]) 09:34, 15 January 2008 (UTC)
-: Seeing as how no-one has changed the article, I added the source and modified the language of the article to reflect what I have said above. [[User:BalazsH|BalazsH]] ([[User talk:BalazsH|talk]]) 14:55, 20 February 2008 (UTC)
-== Mechanism of action ==
-While the article does describe the mechanism by which xylometazoline exerts its effects on a macroscopic scale, there is no mention at all of receptor action. This article definitely needs at least a cursory mention of whether xylometazoline affects the sigma, NMDA, opioid, or other receptor(s), and other pharmacodynamic and pharmacokinetic information would be great too. it's not in my edition of the PDR or I'd add what I could. [[User:Mr0t1633|Mr0t1633]] ([[User talk:Mr0t1633|talk]]) 12:27, 2 July 2008 (UTC)
-some joker obviously changed the half-life to >10 seconds. i suppose its meant to be >10 hours, or i would have to sniff permanentely. lg  <span style="font-size: smaller;" class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/91.113.175.198|91.113.175.198]] ([[User talk:91.113.175.198|talk]]) 14:29, 27 March 2013 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot-->
-== Long Term Use ==
-Apart from Rebound Rhinitis medicamentosa, which I have most certainly suffered, I would really appreciate it if anyone could find anything out about any other side effects from long term use of Xylometazoline or Oxymetazoline. I have been using it ''a lot'' recently and I am worried that there may be other consequences from using this since it is a vasoconstrictor, and while I know the effect is local, could long term use pose a risk to constricting other vessels? If I am using it often then it must be in my blood even in small amounts. I use it once every 24 hours at night and I don't use the full metered dose, in fact I use maybe ¼ of a full metered dose.
-I have tried searching on Google for this but thus far have found little information apart from "not suitable for long term use because of Rebound Rhinitis" or words to that effect. I know this isn't a place for individual medical advice however I believe it would add to the article if there are other possible consequences from long term use.  <span style="font-size: smaller;" class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/86.0.201.161|86.0.201.161]] ([[User talk:86.0.201.161|talk]]) 13:17, 6 June 2013 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot-->
-==Moved from article==
-I have moved the following content here because it lacks context/explanation. If anyone wants to use it to improve the article, here it is. -- [[User:Edgar181|Ed]] ([[User talk:Edgar181|Edgar181]]) 20:17, 8 October 2015 (UTC)
-:<nowiki>[[File:Xylometazoline synthesis.png|600px|center]] *H. Albrecht, {{US Patent|2868802}} (1959). *H. Albrecht, {{Cite patent|DE|1049387}} (1957).</nowiki>
-== Banned in the US ==
-Despite it being more effective and not causing rebound rhinitis like oxymetazoline, this drug was banned in the United State [[USP]] but is still available for purchase from other countries through Amazon and other online retailers.  <!-- Template:Unsigned IP --><small class="autosigned">—&nbsp;Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/2602:63:C3E6:4400:C42A:BB64:3BEB:44F2|2602:63:C3E6:4400:C42A:BB64:3BEB:44F2]] ([[User talk:2602:63:C3E6:4400:C42A:BB64:3BEB:44F2#top|talk]]) 15:28, 10 November 2016 (UTC)</small> <!--Autosigned by SineBot-->
-== "Sudafed" ==
-The page currently specifies that xylometazoline also goes under the name of Sudafed. Is Sudafed not exclusively the name of a pseudoephedrine based decongestant? [[User:Xsidian|Xsidian]] ([[User talk:Xsidian|talk]]) 20:01, 28 December 2023 (UTC)